Beyond Blue

Beyond Blue is an international market research firm specialising in the pharmaceutical industry. Headquartered in Manchester, the company operates in more than thirty-five countries worldwide. Peter Heideman and his wife founded Beyond Blue in 2005 under the name Blueprint Partnership. Today, over fifty professionals work at the firm across three management levels: project directors, project managers, and project executives. They are supported by a dedicated data analytics team.

Services

Developing a new medicine takes years. Once a pharmaceutical company creates a new drug and completes the legal and testing stages, including (animal) trials, it must determine how to market the product. Beyond Blue delivers market research that guides companies on which audiences and countries to target. These projects typically run for about six months. The firm always gives honest advice. This remains true even if research shows limited interest in the medicine or reveals strong competition from similar drugs.

Approach

When a pharmaceutical company prepares to launch a new drug, it sends proposals to several market research firms, including Beyond Blue. Beyond Blue responds with a clear action plan, a detailed budget, and a tailored presentation. The team always delivers these before the deadline. After the client chooses a firm, Beyond Blue, if selected, investigates which individuals and countries show the most potential for the new drug.

The company partners with field agencies in more than thirty-five countries to conduct interviews with specialists. Sometimes these interviews number as many as three hundred. Beyond Blue then analyses the data and translates it into actionable insights. The team presents these findings to the client. Recommendations often go beyond a simple “go” or “no-go.” They highlight specific countries and target audiences most likely to drive the drug’s success.

Quality

Beyond Blue’s success rests on the expertise of its people. Every new team member brings specialised knowledge and receives further internal training. The firm prioritises quality over quantity. It has even turned down projects when the right experts were not available. This unwavering focus on quality has earned Beyond Blue the trust of pharmaceutical companies. These companies rely on the firm to handle their most complex and demanding projects.